PRTA : Analysis & Opinions

  1. Illumina Tops Q4 Earnings on Solid Revenues, Margin Growth - ...

    January 28, 2015
    Illumina's (ILMN) full year 2014 adjusted earnings came in at $2.74 per share, beating the Zacks Consensus Estimate by 3.4% ...
  2. Elan Continues To Make Baffling Strategic Decision

    May 21, 2013
    Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
  3. Elan Hives Off Prothena - Analyst Blog

    December 27, 2012
    Elan Corporation, plc (ELN), a neuroscience-based biotechnology company, recently completed the separation of a significant ...
Trading Center